
In response to a recent hearing of the Senate Special Committee on Aging to examine factors contributing to price spikes in off-patent drugs", the Generic Pharmaceutical Association and 10 stakeholder groups representing pharmacists, chain drug stores, pharmacy benefit managers, public and private retirement systems, and others, sent a letter to the Committee calling for consideration of the Fair Access to Safe and Timely Generics Act (H.R. 2841) to improve competition in the pharmaceutical marketplace.














